Skip to content
DefDex

Federal award

EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.

HDTRA114C0122

Contract

Obligated and Ceiling

Obligated (net)
$16,379,651.89
Ceiling (potential value, not spending)
$17,220,819.89
Current value
$16,379,651.89
Gross positive obligations
$16,379,651.89

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
EMERGENT BIOSOLUTIONS INC. · M7ZHZ4P2MDG4
Awarding agency
Department of War · sub-agency 9761 · office HDTRA1
Funding agency
Department of War · sub-agency 9761
Product or service (PSC)
AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
HDTRA114C0122
Award type code
D
Actions
20 · Aug 11, 2014 to Aug 7, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History20

Award actions
DateFYModAction typeObligationCompany in company totals
Aug 7, 2019FY2019P00019B$0.00
—
Jun 7, 2019FY2019P00018C$400,000.00
—
Apr 12, 2019FY2019P00017B$307,610.89
—
Jan 31, 2019FY2019P00016C$2,163,438.00
—
Oct 31, 2018FY2019P00015B$0.00
—
Jun 8, 2018FY2018P00014C$3,533,077.46
—
Mar 22, 2018FY2018P00013G$99,787.00
—
Mar 13, 2018FY2018P00012M$0.00
—
Dec 8, 2017FY2018P00011C$1,200,000.00
—
Nov 21, 2017FY2018P00010C$100,000.00
—
Mar 23, 2017FY2017P00009G$697,031.54
—
Oct 31, 2016FY2017P00008M$802,510.00
—
Aug 31, 2016FY2016P00007M$0.00
—
May 10, 2016FY2016P00006B$0.00
—
Sep 11, 2015FY2015P00005J$461,966.00
—
May 29, 2015FY2015P00004M$0.00
—
Jan 22, 2015FY2015P00003A$50,250.00
—
Oct 2, 2014FY2015P00002M$0.00
—
Aug 12, 2014FY2014P00001M$0.00
—
Aug 11, 2014FY20140—$6,563,981.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.